Page last updated: 2024-08-22

norsolorinic acid and Urinary Bladder Neoplasms

norsolorinic acid has been researched along with Urinary Bladder Neoplasms in 1 studies

*Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, JK; Chiang, YM; Hsu, YL; Kuo, PL; Wang, CC	1

Other Studies

1 other study(ies) available for norsolorinic acid and Urinary Bladder Neoplasms

Article	Year
Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway. Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:11 Topics: Anthraquinones; Apoptosis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Fas Ligand Protein; fas Receptor; G1 Phase; Growth Inhibitors; Humans; Membrane Proteins; Protein Binding; Resting Phase, Cell Cycle; Signal Transduction; Urinary Bladder Neoplasms	2008

Article

Year

Norsolorinic acid inhibits proliferation of T24 human bladder cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas/membrane-bound Fas ligand-mediated apoptotic pathway.

Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:11

Topics: Anthraquinones; Apoptosis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Fas Ligand Protein; fas Receptor; G1 Phase; Growth Inhibitors; Humans; Membrane Proteins; Protein Binding; Resting Phase, Cell Cycle; Signal Transduction; Urinary Bladder Neoplasms

2008